Description
Challenge accepted. Our country has made numerous strides in advancing patient care, and, more particularly, in increasing efforts to ensure that lives within the national opioid crisis are saved and/or improved. One of those positive strides involves the FDA approval of abuse-deterrent formulation (ADF) opioid medications, with the aim of preventing the transition from the misuse and/or abuse of prescription opioid medications to illicit (and possibly laced) diacetylmorphine (a.k.a. heroin). One may ask:
How do these formulations work?
What abuse-deterrent formulation (ADF) opioid medications are not only available on the U.S. market, but also specifically approved as an ADF opioid medication?
Are these abuse-deterrent formulations really fool-proof?
Well, the street chemists of our country have already accepted the challenge to be knowledgeable on all of the above, so now it’s our turn as healthcare professionals to get up-to-speed on these risk-reduction entities. So please join us for this discussion as part of the overall Substances of Abuse Specialty Pharmacist (SASP) certificate training program.